Cat. No.: DIA-0243241
Product Information | |
---|---|
CAS No. | 1676107-08-6 |
Formula | C36H38F3N3O3 |
Molecular Weight | 617.70 |
SMILES | O=C(C1=CC(C)=CC(C(N[C@@H](CC2=CC=CC=C2)[C@H](O)CNCC3=CC=CC(C(F)(F)F)=C3)=O)=C1)N(C)[C@@H](C4=CC=CC=C4)C |
Target | Beta-secretase |
Product Description | BACE2-IN-1 (compound 3l) is a highly selective BACE2 inhibitor with a K i value of 1.6 nM. BACE2 inhibitors can be used to research of Type 2 Diabetes. |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | 99.34% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Powder: -20°C, 3 years In solvent: -80°C, 6 months; -20°C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.